Edition:
United States

People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,653.50GBp
11:21am EDT
Change (% chg)

16.00p (+0.98%)
Prev Close
1,637.50p
Open
1,646.00p
Day's High
1,671.00p
Day's Low
1,645.00p
Volume
3,781,814
Avg. Vol
8,569,846
52-wk High
1,716.50p
52-wk Low
1,210.27p

Hussain, Shah Abbas 

Mr. Shah Abbas Hussain is President - Europe, Japan & EMAP of GlaxoSmithKline PLC., since September 2012. Abbas joined CET in 2008 and was appointed President, Global Pharmaceuticals in October 2014, having joined the company as President, Emerging Markets & Asia Pacific in June 2008. He joined the ViiV Healthcare Ltd. Board in October 2009 and the Aspen Board in December 2009. Previously, he spent 20 years at Eli Lilly where he held positions including President, Europe and before that Vice President, Europe. He also held positions with Eli Lilly in Australia, the USA, India, Turkey and Germany in several roles including business development, sales and marketing, and management. He has a degree in Medicinal Chemistry & Pharmacology from Loughborough University and was born in Madras, India.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --